X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse VENKYS (I) LIMITED with NESTLE SA - Switz. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VENKYS (I) LIMITED vs NESTLE (Switz.) - Comparison Results

NESTLE (Switz.)
   Change

Nestle SA headquartered in Switzerland, is the world's leading nutrition, health and wellness company. Its product portfolio consists of coffee, water, dairy, ice cream, infant nutrition, performance nutrition, healthcare nutrition, chocolate, frozen... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 VENKYS (I) LIMITED   NESTLE
EQUITY SHARE DATA
    VENKYS (I) LIMITED
Mar-16
NESTLE
Dec-14
VENKYS (I) LIMITED/
NESTLE
5-Yr Chart
Click to enlarge
High Rs6254,875-   
Low Rs2754,250-   
Sales per share (Unadj.) Rs1,451.11,928.4-  
Earnings per share (Unadj.) Rs21.2303.5-  
Cash flow per share (Unadj.) Rs44.6411.0-  
Dividends per share (Unadj.) Rs5.00146.32-  
Dividend yield (eoy) %1.13.2 34.7%  
Book value per share (Unadj.) Rs276.91,472.1-  
Shares outstanding (eoy) m14.093,168.40-   
Bonus/Rights/Conversions BOI-  
Price / Sales ratio x0.32.4 13.1%   
Avg P/E ratio x21.215.0 141.2%  
P/CF ratio (eoy) x10.111.1 90.8%  
Price / Book Value ratio x1.63.1 52.4%  
Dividend payout %23.648.2 48.9%   
Avg Mkt Cap Rs m6,33814,456,097 0.0%   
No. of employees `000NA339.0 0.0%   
Total wages/salary Rs m1,2831,072,540 0.1%   
Avg. sales/employee Rs ThNM18,023.4-  
Avg. wages/employee Rs ThNM3,163.8-  
Avg. net profit/employee Rs ThNM2,836.2-  
INCOME DATA
Net Sales Rs m20,4476,109,941 0.3%  
Other income Rs m35726,537 1.3%   
Total revenues Rs m20,8046,136,479 0.3%   
Gross profit Rs m1,2811,580,876 0.1%  
Depreciation Rs m331340,864 0.1%   
Interest Rs m84751,346 1.6%   
Profit before tax Rs m4621,215,204 0.0%   
Minority Interest Rs m0-29,796 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m163223,939 0.1%   
Profit after tax Rs m299961,469 0.0%  
Gross profit margin %6.325.9 24.2%  
Effective tax rate %35.218.4 191.3%   
Net profit margin %1.515.7 9.3%  
BALANCE SHEET DATA
Current assets Rs m8,4102,258,746 0.4%   
Current liabilities Rs m7,9312,187,846 0.4%   
Net working cap to sales %2.31.2 202.1%  
Current ratio x1.11.0 102.7%  
Inventory Days Days3836 104.8%  
Debtors Days Days5653 104.0%  
Net fixed assets Rs m4,7751,890,281 0.3%   
Share capital Rs m14121,416 0.7%   
"Free" reserves Rs m3,7240-   
Net worth Rs m3,9014,664,346 0.1%   
Long term debt Rs m2,543824,458 0.3%   
Total assets Rs m14,7362,224,760 0.7%  
Interest coverage x1.524.7 6.3%   
Debt to equity ratio x0.70.2 368.8%  
Sales to assets ratio x1.42.7 50.5%   
Return on assets %7.845.5 17.1%  
Return on equity %7.720.6 37.1%  
Return on capital %20.322.5 90.1%  
Exports to sales %0.30-   
Imports to sales %2.50-   
Net fx Rs m-5960-   
CASH FLOW
From Operations Rs m805977,697 0.1%  
From Investments Rs m511-204,319 -0.3%  
From Financial Activity Rs m-1,146-707,467 0.2%  
Net Cashflow Rs m17065,911 0.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for NESTLE (Switz.) is Switzerland Francs. All data has been converted at 66.51 Rs / CHF

Compare VENKYS (I) LIMITED With: COCA COLA (US)  TIGER BRANDS (S. Africa)  AVI LTD. (S. Africa)  

Compare VENKYS (I) LIMITED With: REI AGRO LTD.  KAVERI SEED  GUJ.AMB.EXP.  MCLEOD RUSSEL  GSK CONSUMER  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views On News

GSK Consumer: On the Recovery Path (Quarterly Results Update - Detailed)

Jun 20, 2017

While GSK consumer reported muted revenue growth, volumes are seen to be recovering.

A Little Gem in the FMCG Sector (Sector Info)

Jul 18, 2016

Will investing in Bajaj Corp yield high returns on account of a rural revival in sight?

Parag Milk Foods Limited (IPO)

May 4, 2016

Should you subscribe to Parag Milk Foods' initial public offering?

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

VENKYS (I) LIMITED SHARE PRICE


Aug 18, 2017 (Close)

TRACK VENKYS (I) LIMITED

  • Track your investment in VENKYS (I) LIMITED with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON VENKYS (I) LIMITED

VENKYS (I) LIMITED 8-QTR ANALYSIS

COMPARE VENKYS (I) LIMITED WITH

MARKET STATS